2023年5月11日,

得克薩斯州奧斯汀市——(Newsfile corp .) - - - 2023年5月11日)-天使投資協會(ACA)將舉辦“ACA 2023 -天使投資峰會”(ACA峰會)從5月16日至18日在拉斯維加斯。今年旗艦天使投資活動將彙集來自北美的天使投資人向行業專家和網絡學習與社會支持多樣化的投資者更好的投資決策。ACA的創新資助者展示期間,麥克斯韋生物科學(Maxwell),臨床前藥物發現平台公司,將在他們的模仿,提高分子的合成化合物的發展在人類先天免疫係統發現治療廣泛的設計目前無法治愈的傳染病。展示提供了國家和國際知名度承諾,創新公司及其創始人,導致有意義的支持之前,期間和之後的ACA峰會。麥克斯韋被提名後由集團公司論壇被選為“最有價值公司”在最近的一次投資者資本集團公司主辦的世博會論壇中部和東南部在亞特蘭大,佐治亞州。麥克斯韋曾收到很多天使投資人的投資包括從8 +不同的集團公司成員論壇世界各地的章節。超過500人參加,其中包括天使投資者和天使投資人集團運營商,預計在2023年ACA峰會。事件的2.5天的議程包括演講和分組會議的議題,如“投資於市場”和“生命科學是一個投資者的最佳時間是現在。”關於Maxwell Biosciences: Founded in 2016, Maxwell Biosciences, a preclinical drug platform company, develops biomimetic therapeutics - synthetic compounds that imitate key components of the human immune system. Inspired by nature, these low-molecular weight compounds are created by Maxwell's exclusive first-in-class, CLAROMER® brand drug platform and have been shown to be effective in destroying a broad spectrum of infectious pathogens including viruses, bacteria, fungi and biofilm formations, while avoiding healthy cells. Maxwell's drug candidates have been shown to be well-tolerated in human tissues in vitro and in animal studies. Maxwell's technology is protected by granted patents and is led by a world-class team of experienced life science executives. To learn more about Maxwell Biosciences, visit MaxwellBiosciences.com , or follow us on Twitter (@MaxwellBiosci) and LinkedIn. About the Angel Capital Association: ACA is the largest angel investor professional development organization in the world, representing more than 15,000 angels who invest individually or through 250+ angel organizations, online platforms, and family offices. ACA members work alongside motivated, successful early-stage investors to identify prospective investments, conduct due diligence research, mentor and advise early-stage companies and enhance local startup ecosystems. About Keiretsu Forum: Keiretsu Forum is a global investment community of accredited private equity investors, venture capitalists and corporate/institutional investors. Keiretsu Forum members belong to over 55 chapters around the world and invest in high-quality, diverse investment opportunities. Keiretsu Forum is a conglomeration of individuals or small companies organized around private equity funding for mutual benefit. Through a holistic approach, Keiretsu intends to provide the highest quality deal-flow and investment opportunities. Contact Info: Maxie McFarland, Maxie@Maxwellbiosciences.com , 303-808-2503 To view the source version of this press release, please visit https://www.newsfilecorp.com/release/165721 Sign up for Alerts Sign up to receive news releases by email for Maxwell Biosciences, Inc. or all companies belonging to the Biotechnology, Pharmaceuticals industries. 2023-05-11 11:00 AM EDT